Award
NIH Reporter #1F31HL182293-01
CFTR gene correction via targeted exon replacement
Recipient
University of Texas at Austin
Award Amount
$41,057.00
Ceiling
$41,057.00
Awarded
September 03, 2025
Identifier
1F31HL182293-01
The project will investigate a gene-editing strategy intended to safely and efficiently replace CFTR exon 12, with the potential to provide a treatment for people with cystic fibrosis who lack therapeutic options.
Description
Project to develop retron editing to replace the entire CFTR exon 12 without creating a DNA break, potentially addressing cystic fibrosis mutations that do not respond to approved CFTR modulators.